Last reviewed · How we verify
Isotonic fluid — Competitive Intelligence Brief
phase 3
Crystalloid fluid / Intravenous fluid replacement
Critical Care / Emergency Medicine / Perioperative Medicine
Small molecule
Live · refreshed every 30 min
Target snapshot
Isotonic fluid (Isotonic fluid) — Johns Hopkins University. Isotonic fluid restores intravascular volume and maintains osmotic balance to correct dehydration and electrolyte disturbances.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Isotonic fluid TARGET | Isotonic fluid | Johns Hopkins University | phase 3 | Crystalloid fluid / Intravenous fluid replacement |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Crystalloid fluid / Intravenous fluid replacement class)
- Johns Hopkins University · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Isotonic fluid CI watch — RSS
- Isotonic fluid CI watch — Atom
- Isotonic fluid CI watch — JSON
- Isotonic fluid alone — RSS
- Whole Crystalloid fluid / Intravenous fluid replacement class — RSS
Cite this brief
Drug Landscape (2026). Isotonic fluid — Competitive Intelligence Brief. https://druglandscape.com/ci/isotonic-fluid. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing